> top > docs > PMC:7307149 > spans > 21119-21447 > annotations

PMC:7307149 / 21119-21447 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T142 54-57 Body_part denotes HLA http://purl.org/sig/ont/fma/fma84795
T143 99-102 Body_part denotes HLA http://purl.org/sig/ont/fma/fma84795

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T93 115-123 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T211 58-65 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T212 124-131 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T213 182-183 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
383 115-123 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T113 0-328 Sentence denotes However, we do at this juncture recommend integrating HLA testing into clinical trials and pairing HLA typing with COVID-19 testing where feasible to more rapidly develop and deploy a predictor(s) of viral severity in the population and, potentially, to tailor future vaccination strategies to genotypically at-risk populations.